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Abstract: In this article international trends in surgical practice in girls with congenital adrenal hyper-
plasia (CAH) are evaluated. All cases that had been classified in the I-CAH/I-DSD registry as 46,XX
CAH and who were born prior to 2017 were identified. Centers were approached to obtain information on
surgical decision making. Of the 330 included participants, 208 (63.0%) presented within the first month
of life, and 326 (98.8%) cases were assigned female. Genital surgery had been performed in 250 (75.8%).
A total of 64.3, 89.2, and 96.8% of cases residing in Europe, South America and Asia, respectively, had at
least one surgery. In a logistic regression model for the probability of surgery before the second birthday
(early surgery) over time an increase of probability for early vaginal surgery could be identified, but not
for clitoral surgery or both surgeries combined. Genitoplasty in girls with CAH remains controversial.
This large international study provides a snapshot of current practice and reveals geographical and tem-
poral differences. Fewer surgeries were reported for Europe, and there seems to be a significant trend
towards aiming for vaginal surgery within the first 2 years of life.
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Abstract
In this article international trends in surgical practice in girls 
with congenital adrenal hyperplasia (CAH) are evaluated. All 
cases that had been classified in the I-CAH/I-DSD registry as 
46,XX CAH and who were born prior to 2017 were identified. 
Centers were approached to obtain information on surgical 
decision making. Of the 330 included participants, 208 
(63.0%) presented within the first month of life, and 326 
(98.8%) cases were assigned female. Genital surgery had 
been performed in 250 (75.8%). A total of 64.3, 89.2, and 
96.8% of cases residing in Europe, South America and Asia, 
respectively, had at least one surgery. In a logistic regression 
model for the probability of surgery before the second birth-
day (early surgery) over time an increase of probability for 
early vaginal surgery could be identified, but not for clitoral 
surgery or both surgeries combined. Genitoplasty in girls 
with CAH remains controversial. This large international 
study provides a snapshot of current practice and reveals 
geographical and temporal differences. Fewer surgeries 
were reported for Europe, and there seems to be a significant 
trend towards aiming for vaginal surgery within the first 2 
years of life. © 2021 The Author(s).
Published by S. Karger AG, Basel
Introduction
Congenital adrenal hyperplasia (CAH) is the most 
common diagnosis in infants with virilization, 46,XX 
DSD. The incidence of classic virilising CAH is about 
1:15,000 in most populations in the world [Speiser et al., 
2010]. More than 95% of cases are caused by 21-hydroxy-
lase deficiency, which is characterized by defective gluco-
corticoid synthesis in all patients and mineralocorticoid 
synthesis in some. Precursors to cortisol and aldosterone 
accumulate and are shunted toward androgen produc-
tion, starting in fetal life. The prenatal excess of andro-
gens results in virilization of 46,XX infants [Speiser et al., 
2010]. Most girls with CAH present with atypical genita-
lia [Merke and Auchus, 2020], and although they have 
traditionally been treated by early sex-conforming sur-
gery, this approach has increasingly been debated with 
clinicians/parents opting not to undertake any surgery 
before the age of consent [Kolesinska et al., 2014; Wolffen-
buttel and Crouch, 2014; Bougneres et al., 2017]. Studies 
performed on large data sets from international cohorts 
such as the International DSD registry (www.i-dsd.org) 
have been successfully used in different scientific projects 
[Ahmed et al., 2014]. With the recent extension of this 
registry platform to include patients with CAH (www.i-
cah.org), the current study was designed to evaluate 
changes over time in CAH-related surgical practice. In 
particular, we wanted to find out whether there was a 
change over time in the rate of early feminizing genito-
plasty. We divided our dataset of patients into 2 equally 
distributed groups (1996–2006, 2007–2017). By chance, 
the distribution coincidenced with the Chicago consen-
sus of 2006, which was followed by many important con-
sensus and position papers concerning care of patients 
with DSD (Office of the High Commissioner for Human 
Rights, United Nations for Intersex Awareness, https://
www.ohchr.org/EN/Issues/LGBTI/Pages/IntersexPeo-
ple.aspx, 2016; Parliamentary Assembly of the Council of 
Europe, Resolution 2191, https://assembly.coe.int/nw/
x m l / X R e f / X r e f - X M L 2 H T M L - e n .
asp?fileid=24232&lang=en) [Méndez, 2013; Deutsche 
Gesellschaft für Urologie (DGU) e.V., 2016; Mouriquand 
et al., 2016; Cools et al., 2018; Krege et al., 2019].
Material and Methods
The I-DSD and the I-CAH registries are international regis-
tries, approved by the National Research Ethics Service of the Unit-
ed Kingdom, for storage of pseudo-anonymized data. Data are col-
lected as part of routine clinical practice following informed con-
sent of the parents or patients [Kourime et al., 2017]. All cases that 
had been registered until 2018 as 46,XX disorder of androgen ex-
cess due to CAH and who were born prior to 2017 were included 
in this study. We identified 555 patients from 41 centers, who were 
born between 1953 and 2016. These centers were approached to 
obtain additional information on factors that influenced the op-
tion of performing surgery, timing of surgery, type of surgery, and 
the length of the follow-up period (the questionnaire for the cen-
ters is available in online suppl. Table 1; for online suppl. material, 
see www.karger.com/doi/10.1159/517055).
The centers were provided a 6-month period to respond, and 
during this period 21 (51.2%) centers completed and returned the 
questionnaires on a total of 334 of 555 eligible cases (60.2%). Of 
the 334 completed questionnaires, 330 (98.8%) from 12 countries 
in Europe (15 centers, n = 199), Asia and Turkey (4 centers, n = 
94), and South America (2 centers, n = 97) were suitable for analy-
sis. In this study, we included only patients born between January 
1995 and December 2015 who had their first presentation between 
January 1996 and December 2016 before their first birthday (n = 
184) (Fig. 1). Out of the 184 patients included, 104 patients (56%) 
were registered in European centers, 59 patients (32%) were regis-
tered in Asian centers, and 21 patients (11%) were registered in 
South American centers. Prader score at first presentation was 




available for 122 patients (66%), external masculinization score 
(EMS)  [Ahmed et al., 2000] at first assessment was available for 67 
patients (36%). A total of 90 patients (49%) had their first presen-
tation before or in 2006, 94 patients (51%) presented in 2007 or 
later.
Statistical Analysis
Early surgery was defined as surgery before 24 months of life. 
For univariate analysis, a logistic regression of the probability of 
early surgery for patients presenting before their first birthday was 
performed. Patients for which no information about early surgery 
was available were considered as missing values. Differences in 
proportions of early surgery before and after 2006 were analyzed 
by a Pearson’s χ2 test, and correlation between early surgery and 
Prader score and EMS were investigated by Wilcoxon tests. In a 
multiple logistic regression model we included the year of first pre-
sentation with an interaction term with the cut off at 2006, and the 
Prader score dichotomized as up to 2 and >2. In a sensitivity anal-
ysis, the calculations were repeated in a nonlinear mixed model 
with the random effect intercept per center. All statistical calcula-
tions were performed with R versions 3.5.1 and 3.6.3.
Results
Clinical Characteristics
Of the 184 cases, 160 patients (87%) presented within 
the first month of life, 15 patients (8%) presented between 
month 1 and end of month 3, and 9 patients (5%) pre-
sented between month 4 and their first birthday. A total 
of 172 patients (93%) had 21-hydroxylase deficiency, 6 
(3%) had 11β-hydroxylase deficiency, and 6 patients (3%) 
had other forms of CAH. At birth, 183 (99%) cases were 
assigned as female, and 1 case was not assigned to any sex. 
At latest assessment, all cases had a female sex assign-
ment. Prader score was available in 122 patients (66%) 
with a median of 4 (IQR: 3–4, range: 0–5; EMS at first as-
sessment was entered for 67 patients (36%) with a median 
of 7 [IQR: 7–9, range: 4–10]).
Surgery
Altogether, 184 patients were born between January 
1996 and December 2016 and had their first presentation 
within the first year of life: 94 patients (51%) presented 
between 1996 and 2006, 90 patients (49%) presented in 
2007 or later. In sum, 51 patients (28%) did not have sur-
gery before their second birthday (no early surgery), 65 
patients (35%) had at least 1 operation before their second 
birthday. For 68 patients (37%) this information was not 
available: for 3 patients it was unclear whether they had 
surgery, 6 patients without surgery had their last follow-
up before their second birthday, and for 59 patients with 
surgery the date of surgery remained unknown. Of those 
65 patients with at least 1 operation before their second 
birthday, 54 patients (83%) had vaginal as well as clitoral 
surgery, 7 patients (10%) had clitoral but no vaginal sur-
gery, 2 patients (3%) had vaginal but no clitoral surgery, 
and 2 patients (3%) had clitoral surgery with no informa-
tion about vaginal surgery. Of the 54 cases who had both 
operations, in 3 (6%) clitoral surgery was performed first, 
in 48 patients (89%) both surgeries were performed si-
multaneously, and for 3 patients this information was not 
available. Age at last follow-up was equally distributed 
between patients with early surgery (median 10, range 
0–20), patients without early surgery (median 10, range 
All cases:
n = 330




First presentation after 1995:
n = 215
First presentation before 
first birthday: n = 184
Born before 1995: n = 71
year of birth n/a: n = 1 
Born after 2015:
n = 9
First presentation 1995: n = 7
Year of first presentation n/a: n = 27
First presentation after first birthday: 
n = 31
Fig. 1. Inclusion/exclusion flow diagram of 
the sample.
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2–19), and patients with unknown early surgery status 
(median 9, range 0–21). The time at first presentation 
(before and after 2006) did not show any association with 
the proportion of early surgeries (Pearsons´s χ2 test, p = 
0.59). No trend in the distribution of missing data could 
be perceived, therefore we are confident not to have any 
bias due to missing values (Table 1; Fig. 2).
Surgery and Geography
Of the 184 cases, the number of cases from Europe, 
South America, and Asia were 104 (56.5%), 21 (11.4%), 
and 59 (32.1%), respectively, and the number of girls who 
had surgery reported in these 3 regions was 76 (73.0%), 
17 (81.0%), and 58 (98.3%), respectively. The number of 
girls who had early surgery reported in these 3 regions 
was 33 (31.7%), 10 (47.6%), and 22 (37.3%), respectively.
The median Prader stage for these 3 regions was 3 (nor-
mal female–5), 3 (3–5), and 4 (2–5), respectively. Altogeth-
er, 90 girls presented before 2006, 94 presented in 2007 or 
later. Early surgery was reported for 35 girls of the former 
group (38.9%) and for 30 girls of the second group (32.9%).
No clear difference in the frequency of reported early 
surgery before and after 2006 can be perceived, and a χ2 
test identified no difference in proportions before and af-
ter 2006. Also, when geographical regions were analyzed 
separately, proportions of girls with early surgery before 
and after the statement did not differ substantially (Eu-
rope: 18 out of 49 [36.7%] before 2006 vs. 15 out of 57 
[27.3%] after 2006; South America: 5 out of 11 [45.5%] 
before vs. 5 out of 10 [50%] after 2006; Asia: 12 out of 30 
[40%] before vs. 10 out of 29 [34.5%] after). Due to the 
geographic bias of this study no further analysis was per-
formed.
Clinical Features Associated with the Likelihood of 
Surgery
Prader score was available for 34 patients without ear-
ly surgery (median: 3, range: 0–5, IQR: 2–4), 45 patients 
with early surgery (median: 4, range: 2–5, IQR: 3–4), and 
43 patients with unknown early surgery status (median: 
4, range: 0–5, IQR: 3–4). A Wilcoxon rank sum test iden-
tified differences between Prader scores of patients with 
and without early surgery (p = 0.002). EMS was available 
for 67 patients. Median EMS reported for those who did 
not have early surgery (n = 17) was 7 (range: 4–10, IQR: 
6–8), median EMS for those who had surgery (n = 28) was 
Patients (%) presenting in 
2006 or before
Patients (%) presenting 
in 2007 or later
No early surgery 24 (27) 27 (29)
At least one early surgery 35 (39) 30 (32)
Information not available 31 (34) 37 (39)
unknown date: 28 unknown date: 31
lost to follow-up: 2 lost to follow-up: 4
unclear if surgery: 1 unclear if surgery: 2
Table 1. Probability of having early 






















Fig. 2. Estimated trend for proportion of 
early surgeries over time.




7 (range: 4–10, IQR: 7–7), median EMS for patients with 
unknown early surgery status (n = 22) was 7 (range: 4–10, 
IQR: 7–9). A Wilcoxon rank sum test identified no differ-
ences between first EMS of patients with and without sur-
gery (p = 0.55). First EMS was available for 67 girls and 
missing for 117 girls, with median 7 and range 4–10. 
Prader Score was available for 122 girls and missing for 
62 girls, with median 4 and range 0–5. For 51 patients 
(27.7%) neither Prader nor EMS score were available.
Analysis of data regarding the influence of patient, 
parent, clinician, society, religion, and media for the de-
cision-making process was not possible due to heteroge-
neity and incompleteness.
Multiple Logistic Regression
Logistic regression was performed for the proportion 
of early surgery regarding the year of first presentation. 
No significant change of the proportion of early surgeries 
over the year of first presentation was identified (OR = 
0.99, 95% CI = [0.92, 1.07], p = 0.780). Inclusion of an in-
teraction between time and the cut off at 2006 did not 
identify a change in trend of the proportion of early sur-
gery after 2006 (OR = 1.23, 95% CI = [0.94, 1.62], p = 
0.135). For those patients with known Prader score, in a 
logistic regression model with covariates year of first pre-
sentation and dichotomized Prader score, no trend could 
be identified (OR: 1.05, 95% CI = [1.00, 1.11], p = 0.067), 
but a higher proportion of early surgeries was associated 
with a Prader score >2 (OR: 6.54, 95% CI = [1.84, 31.11], 
p = 0.007). In a sensitivity analysis, nonlinear mixed mod-
els with the random effect center were analyzed which 
gave the same results (data not shown).
Discussion
Despite the widespread controversy in the medical 
community, media, and general population, there is a sig-
nificant lack of reliable or prospective data on genital sur-
gery in CAH. Therefore, the subject of this study was to 
evaluate the current surgical practice and changes over 
time in children with CAH within the I-CAH and I-DSD 
registries. Data from over 184 girls with CAH were ac-
cessed and analyzed to investigate trends in early surgery. 
To our knowledge this is the largest international study 
of a contemporary approach to surgery in these patients.
Apart from one patient, where information on sex as-
signment was not available, all patients were raised as 
girls, and around 35% had at least one reported genital 
surgery before their second birthday. When early surgery 
was performed, the majority of all patients had complete 
urogenital reconstruction in one step. When a staged ap-
proach was followed, clitoroplasty preceded vaginoplas-
ty. Postponing surgery is a concept that is not reflected by 
our data: no change in the proportion of early surgeries 
over time could be identified, and there was no change in 
the probability of having early surgery over time. The cur-
rent recommendation is to perform surgery only in cases 
of severe virilization (Prader III, IV, and V) [Hughes et 
al., 2006]. Wolffenbuttel and Crouch [2014] recommend 
one stage surgery for severely virilized genitalia and de-
ferring surgery in milder cases whenever possible. Differ-
ent expert opinion papers recommend early single-stage 
genital repair for girls with severe virilization, performed 
by experienced surgeons [Speiser et al., 2010; Yankovic et 
al., 2013]. On the other hand, non-surgical treatment or 
delayed surgery is considered to be an option for patients 
with a phenotypical genital variation. Recently, a study 
suggested deferring genital surgery in girls with 21-hy-
droxylase deficiency into adolescence as a feasible option. 
However, none of these girls have reached puberty so far 
[Bougneres et al., 2017]. On the contrary, there is infor-
mation on individuals with complete masculinization, 
46,XX karyotype, and CAH raised as boys, with some dis-
playing gender dysphoria and some not. The social sup-
port seams to play a crucial role in the development of 
their sexual identity. de Jesus et al. [2019] reported a high-
er percentage of gender dysphoria in individuals with 
46,XX CAH raised as males compared to those raised as 
females, 9 and 18.4% respectively, but with a confounding 
factor considering late diagnosis in most male-raised in-
dividuals [Lee et al., 2010; Khattab et al., 2017]. A consen-
sus statement recently published stresses the importance 
of informed consent and a holistic, multidisciplinary care 
for the patients, and postponing the genital surgery until 
the individual is old enough to be actively involved in the 
decision whenever possible was advised [Cools et al., 
2018].
Genital surgery has become the most controversial part 
of DSD management. Reconstructive surgery of the geni-
talia, historically thought to be in the individual’s best in-
terest by normalizing the phenotype and defining an ac-
ceptable gender role, has been appraised extremely critical 
over the years until in 2012 the UN Report of the Special 
Rapporteur on torture and other cruel, inhuman, or de-
grading treatment or punishment underlines the impor-
tance of non-discriminating, no forced gender-confirm-
ing surgery and specialized holistic care [Méndez, 2013]. 
Finally, in 2017 the Council of Europe published the reso-
lution 2191 called “Promoting the human rights of and 
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eliminating discrimination against intersex people resolu-
tion” (available at  https://assembly.coe.int/nw/xml/XRef/
Xref-XML2HTML-en.asp?fileid=24232&lang=en) em-
phasizing the right of physical integrity in children or in-
fants who are unable to give consent and whose gender 
identity is unknown. This practice has largely been ad-
opted in DSD management. However, there is controver-
sy whether this strict policy is also applicable to individu-
als with CAH raised as females: on one hand there is a 
tendency to exclude CAH from the umbrella term DSD 
(pushed by affected individuals themselves) and on the 
other hand the majority of individuals with CAH raised as 
females and their families still support early surgery 
[Deutsche Gesellschaft für Urologie (DGU) e.V., 2016; 
Szymanski et al., 2020; Shalaby et al., 2021].
In a recent German interdisciplinary consensus paper, 
adolescents and young women with CAH from a group 
of about 600 patients with CAH declared agreement with 
surgery performed early in childhood, and they do not 
consider early correction of urogenital sinus as cosmetic 
procedures [Krege et al., 2019]. Jesus [2018] also supports 
these findings. In a study performed in 2015 in the USA, 
only 219/573 (38.2%) received feminizing genitoplasty 
over a 4-year period of surveillance. Median patient age 
was <1 year at first procedure in the combined genito-
plasty cohort and 74% of combined procedures were per-
formed at <2 years [Sturm et al., 2015]. In other US cen-
ters management and timing of surgery differs signifi-
cantly. In a study from 2010 it was shown that feminizing 
genitoplasty procedures were performed in 46% of girls 
and 60% of all procedures were performed by the age of 
2 years [DaJusta et al., 2010].
Ethics of allowing parents to consent for genital sur-
geries that could permanently impair the genital sensa-
tion of the child are difficult [Schoer et al., 2018]. Due to 
the poor quality of data, our survey was not able to ana-
lyze trends whether media, society, religion, and others 
influence the decision-making process significantly. 
However, the role of cultural, religious, and social atti-
tudes in the decision-making process as well as patients’ 
and parents’ opinion will require a more detailed investi-
gation [Joint LWPES/ESPE CAH Working Group, 2002; 
Mouriquand et al., 2016].
Conclusion
In summary, our study shows no change of practice 
over time in feminizing genitoplasty in girls with 46,XX 
CAH. Global disease registries such as the I-DSD and I-
CAH registries represent an important resource for long-
term monitoring of surgical practice and its outcomes. 
Inclusion of patient-reported outcome parameters in the 
I-DSD/I-CAH registries will be of tremendous impor-
tance in order to obtain feedback from individuals with 
DSD directly and not only through caring DSD teams.
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